Randomized Trial of Topotecan With M6620, an ATR Kinase Inhibitor, in Small Cell Lung Cancers and Small Cell Cancers Outside of the Lungs
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Centre Oscar Lambret
Stanford University
University of Washington
Fred Hutchinson Cancer Center
Mayo Clinic
National Cancer Institute (NCI)
Roswell Park Cancer Institute
City of Hope Medical Center
Vanderbilt-Ingram Cancer Center
National Cancer Institute (NCI)
Jonsson Comprehensive Cancer Center
City of Hope Medical Center
University of Washington
Beidahuang Industry Group General Hospital
University of Michigan Rogel Cancer Center
National Cancer Institute (NCI)
Northwestern University
Intuitive Surgical
Intuitive Surgical
University of Washington
National Institutes of Health Clinical Center (CC)
City of Hope Medical Center
Emory University
National Cancer Institute (NCI)
UNICANCER
University of Arizona
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
The Netherlands Cancer Institute
University of Washington
Assistance Publique Hopitaux De Marseille
Mayo Clinic
Istituto Clinico Humanitas
Abramson Cancer Center at Penn Medicine
University Hospital, Grenoble
Barbara Ann Karmanos Cancer Institute
Washington University School of Medicine
Centre Georges Francois Leclerc
Alliance for Clinical Trials in Oncology
Washington University School of Medicine
Centre Hospitalier Universitaire de Saint Etienne
National Cancer Institute (NCI)
Vanderbilt-Ingram Cancer Center